loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Deferasirox

    Menu

    Deferasirox

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 404Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 207968 / DOSAGE - GRANULE;ORAL - 180MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DEFERASIROX(UNII: V8G4MOF2V9)
    (DEFERASIROX - UNII:V8G4MOF2V9)     		DEFERASIROX90mg | 180mg | 360mg

    Inactive Ingredients

    Ingredient Name
    Catalent Germany Schorndorf GmbH
    Ascend Laboratories, LLC
    Cipla USA Inc.
    CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)  
    CROSPOVIDONE(2S7830E561)
    HYDROGENATED CASTOR OIL(ZF94AP8MEY)  
    LACTOSE MONOHYDRATE(EWQ57Q8I5X)  
    MAGNESIUM STEARATE(70097M6I30) 
    MICROCRYSTALLINE CELLULOSE 101(7T9FYH5QMK)  
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U)  
    POLOXAMER 188(LQA7B6G8JG)
    POVIDONE K30(U725QWY32X)
    SILICON DIOXIDE(ETJ7Z6XBU4) 
    SODIUM HYDROXIDE(55X04QC32I)  
    SODIUM STEARYL FUMARATE(7CV7WJK4UI)